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Abstract
Patient-reported outcomes (PROs) refer to any report com-
ing directly from patients about how they function or feel in 
relation to a health condition or its therapy. PROs have been 
applied in medicine for the assessment of the impact of clin-
ical phenomena. Self-report scales and procedures for as-
sessing physical pain in adults have been developed and 
used in clinical trials. However, insufficient attention has 
been dedicated to the assessment of mental pain. The aim 
of this paper is to outline the implications that assessment of 
mental pain may entail in psychiatry and medicine, with par-
ticular reference to a clinimetric index. A simple 10-item self-
rating questionnaire, the Mental Pain Questionnaire (MPQ), 
encompasses the specific clinical features of mental pain 
and shows good clinimetric properties (i.e., sensitivity, dis-
criminant and incremental validity). The preliminary data 
suggest that the MPQ may qualify as a PRO measure to be 
included in clinical trials. Assessment of mental pain may 
have important clinical implications in intervention research, 
both in psychopharmacology and psychotherapy. The trans-
diagnostic features of mental pain are supported by its as-
sociation with a number of psychiatric disorders, such as de-
pression, anxiety, eating disorders, as well as borderline per-
sonality disorder. Further, addressing mental pain may be an 
important pathway to prevent and diminish the opioid epi-
demic. The data summarized here indicate that mental pain 
can be incorporated into current psychiatric assessment and 
included as a PRO measure in treatment outcome studies.
© 2019 S. Karger AG, Basel
Introduction
There has been growing emphasis on patient-reported 
outcomes (PROs) – any report coming directly from pa-
tients about how they function or feel in relation to a 
health condition or its therapy [1]. Patients’ perspective 
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may support analyses of efficacy and effectiveness, exam-
inations of quality of care, and pharmacovigilance. Some 
PROs focus on self-rated evaluation of specific disease-
related conditions, such as cancer, pain, or depression. 
Other indices are focused on more general perceptions, 
such as quality of life. PROs are also clinically useful for 
detecting the burden and impact of symptoms on quality 
of life and psychological well-being of patients [2]. Phys-
ical pain is frequently assessed, generally for determining 
what type of intervention is likely to affect subjective per-
ception of pain best. Self-report scales and procedures for 
assessing physical pain in adults have been developed and 
used in clinical trials [3]. PROs are part of the general psy-
chosomatic approach [4] that considers how a patient 
perceives symptoms and how this appraisal affects his/
her functioning and relationships with others as part of 
the disease process [5–7]. The need to include consider-
ation of functioning in daily life, productivity, perfor-
mance of social roles, intellectual capacity, emotional sta-
bility, and well-being has emerged as a crucial part of clin-
ical investigation and patient care [5]. Psychosomatic 
medicine pioneered the self-rated evaluation of psycho-
logical status in medical conditions. In psychiatry, self-
rating scales, long before the appearance of PROs, have 
been part of assessment tools for clinical trials [8, 9]. A 
number of sensitive and valid instruments have been de-
veloped for assessing mood, anxiety, and other psycho-
logical symptoms [9, 10]. However, assessment of mental 
pain has been neglected by clinical studies in psychiatry 
[11, 12]. For instance, the comprehensive Handbook of 
Psychiatric Measures [13] did not include a specific in-
strument for mental pain. 
The aim of this paper is to outline the clinical implica-
tions that assessment of mental pain may entail in psy-
chiatry and medicine, with particular reference to a clini-
metric index that may have considerable potential in pur-
suing such a goal.
Clinical Characterization of Mental Pain
There have been various definitions of mental pain in 
the literature, where, in addition to mental pain, terms 
such as psychic pain, emotional pain, psychological pain, 
social pain, emptiness, psychache, internal perturbation, 
and psychological quality of life have been used to refer 
to this construct [11, 14, 15]. 
Sometimes, according to such definitions the concept 
is placed in a specific context. Shneidman [16] defined it 
as “psychache,” an acute state of intense psychological 
pain associated with feelings of guilt, anguish, fear, panic, 
loneliness, and helplessness, which is at the core of the 
suicidal process. Orbach et al. [17] defined mental pain as 
“a wide range of subjective experiences characterized as a 
perception of negative changes in the self and its function 
that is accompanied by strong negative feelings,” and 
completed suicide can be viewed as a means of alleviating 
a painful internal state. Indeed, higher levels of psycho-
logical pain were found to be associated with suicidal ide-
ations and acts [18].
Other definitions are broader. According to Cassel 
[19], suffering can be defined as a state of severe distress 
that occurs when an impending destruction of the person 
is perceived. “Suffering is experienced by persons, not 
merely by bodies, and has its source in challenges that 
threaten the intactness of the person as a complex social 
and psychological entity” [19]. As Sensky [20] noted, the 
term “suffering”, however, may have different meanings 
to different people. Expressions such as “suffering from 
intense pain,” “suffering from a terminal illness,” or even 
“suffering a hangover” are indicative of these ambiguities.
Meerwijk and Weiss [21] attempted to identify some 
common characteristics of psychological pain (they pre-
ferred this term to mental pain), that were identified in 
unpleasant feelings, appraisal of an inability or deficiency, 
and its features of unsustainability. They advocated an 
operational and consensus definition beyond the various 
conceptualizations of psychological pain [21].
Engel [22] pointed out that grief is a cause of mental 
pain, produces a variety of bodily and psychological 
symptoms, and interferes with our ability to function ef-
fectively. Grief may occur after the loss of a valued object, 
being it a loved person, a cherished possession, a job, sta-
tus, home, country, an ideal, or a part of the body. Schmale 
[23] underscored that grieving, as with other forms of loss 
and life change, is a highly personal reaction, which is 
based on individual past experiences, current life circum-
stances, and future aspirations. Medical illness may con-
stitute a significant loss, particularly with regard to the 
state of good health and/or well-being [23].
Engel [22] wondered whether grief could be consid-
ered as a disease and challenged its traditional conceptu-
alization, which tends to be restricted to what can be un-
derstood or recognized by the physician [22, 24]. Simi-
larly, mental pain may be a universal experience that has 
a natural course and may become the source of positive 
insights that prelude to adaptive changes. 
The borderland between mental pain and pain re-
ferred to the body is of difficult definition, since pain al-
ways involves a psychological component [25]. Engel [25] 
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defined pain “as a psychological experience involving the 
concepts of injury and suffering, but not contingent on 
actual physical injury. The idea of injury as well as the 
need to suffer may lead to pain, just as a real lesion or 
injury may do. Similarly, the need not to suffer or not 
to accept the fact that an injury is painful may render a 
“painful” injury “painless.”
The Link between Mental and Physical Pain
According to the definition of the International Asso-
ciation for the Study of Pain (IASP), “pain is an unpleas-
ant sensory and emotional experience associated with ac-
tual or potential tissue damage or described in terms of 
such damage” [26]. This definition clearly determines 
that in addition to nociceptive activation of the brain, 
pain is an individual and internal experience, which is 
consciously perceived, modulated, and transformed ac-
cording to its emotional context [27]. Moreover, the clin-
ical manifestations of pain can be seen as the result of the 
complex interplay between biological factors, psycholog-
ical processes, and social influences. Pain-related neural 
brain networks fluctuate spontaneously, therefore the 
pain experience is a result of dynamic communication of 
networks shaping cognition and behavior, called the 
“pain connectome” [28]. When acute pain arises, the eti-
ology can be defined in most cases. However, chronic 
pain may occur in the absence of prior tissue injury and 
may be the result of dyssynchrony and disruption of the 
pain connectome [29]. 
Recent neuroimaging studies have shown that physical 
pain evoked by nociceptive stimuli involves similar brain 
regions activated by various emotional and behavioral 
states [27]. This hierarchical, multilevel neural network is 
responsible for the process of experiencing physical pain 
(spinothalamic tract to posterior thalamus – 1st level). 
This information is further processed and enriched with 
conscious perception and attentive and cognitive modu-
lation (anterior cingulate cortex, insula, prefrontal cortex, 
posterior parietal cortex – 2nd level), leading to somatic 
or vegetative responses. Finally, pain perception and 
modulation are enriched by the emotional context and 
individual psychological factors (orbitofrontal cortex, 
perigenual anterior cingulate cortex, anterolateral pre-
frontal cortex – 3rd level) to formulate individual pain 
memory; 2nd and 3rd level brain regions modulate the 
incoming nociceptive stimuli as either inhibitory or fa-
cilitatory through interactions with descending tracts in 
the spinal cord [27]. 
In many cases pain awareness in chronic pain (“chron-
ic pain phenotype”) is the result of ongoing subconscious 
changes in brain function modulated by internal (e.g., ge-
netic, inflammatory, repeated nociceptive events) and ex-
ternal (e.g., environment, socioeconomic levels) process-
es [29]. In healthy populations, intrinsic brain activity or-
ganizes brain networks to interpret, respond, and predict 
environmental stimuli [30, 31]. This intrinsic activity 
shows similar networks across populations and over time 
and does not have a pain phenotype, although there are 
differences in relation to sex and certain psychological 
factors (substance use disorders and mood disorders) 
[29]. Early development injuries (e.g., early child amputa-
tion) and acute pain attacks (e.g., migraine) may result in 
delayed onset of chronic pain, which is related to the un-
derlying alterations in brain network efficiency, connec-
tivity, and strength [29]. Psychological factors, particu-
larly depression, may reorder the neural network, pro-
ducing a chronic pain phenotype without a history of 
prior pain [29]. Environmental factors may also play an 
important role in the development of pain. Chronic ther-
apeutic use of opioids (e.g., in migraine or in chronic 
pain) may lead to hyperalgesia and further pain chronic-
ity [29]. Physical and psychological trauma accompanied 
by negative emotions (sexual abuse, torture) may contrib-
ute to chronic dysfunction in the brain, resulting in gen-
eralized dysfunctional pain modulation with consequent 
chronic pain at nearly the same level as at the time of the 
initiating event [29, 32, 33]. When the structural and 
chemical changes in the brain and the dyssynchrony and 
disruption of networks reach a tipping point, then con-
scious pain develops [29]. 
Patient-Reported Outcome Measures
Engel [25] acknowledges that a limiting factor in pa-
tient description during an interview is the patient’s ver-
bal capacity: “one must accept the fact that some persons 
simply lack the vocabulary and fluency to report much 
beyond the fact that they are in pain.” This particularly 
applies to the description of mental pain by patients who 
present with alexithymic features [5]. There are two 
methods for assessing mental pain that may be subsumed 
under the rubric of PRO measures and may complement 
clinical interviewing.
One is provided by self-rating questionnaires. A num-
ber of psychometric instruments have been developed: 
the Psychological Pain Assessment Scale (PPAS) [16], the 
Multiple Visual Analog Scale (MVAS) [16], the Psych-
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ache Scale (PAS) [34], the Orbach and Mikulincer Mental 
Pain Scale (OMMP) [35], the Tolerance for Mental Pain 
Scale (TMPS) [36], and the Mee-Bunney Psychological 
Pain Assessment Scale (MBPPAS) [37]. Many of the vali-
dation studies have been conducted in relation to suicide 
attempters.
Another type of measure does not rely on language 
skills and can be used to rapidly elicit patients’ appraisals 
of their suffering [38, 39]. Büchi et al. [38–41] have devised 
a measure called the Pictorial Representation of Illness 
and Self Measure (PRISM), which, in validation studies 
[41], behaves as expected of a measure of suffering and fits 
well with Cassel’s conceptualization of suffering [19, 42].
At present, however, there is insufficient evidence to 
indicate that any of these specific instruments satisfies the 
requirements for inclusion as PROs in clinical trials, ac-
cording to guidelines [43].
Development of a Clinimetric Index
Clinimetrics, the science of clinical measurements, of-
fers important opportunities for assessing clinical phe-
nomena such as mental pain [10, 44, 45]. Such assessment 
is generally neglected in standard psychiatric and medical 
evaluations, where exclusive reliance on the symptoms of 
the psychiatric diagnostic criteria may not reflect the clin-
ical picture of patients in practice [46].
A simple clinimetric index (a 10-item yes/no question-
naire), the Mental Pain Questionnaire (MPQ) (Table 1), 
was developed [47, 48]. In psychometrics, homogeneity of 
components, measured by statistical tests such as Cron-
bach’s alpha, is often regarded as the most important re-
quirement for a rating scale. However, the same properties 
that give a scale a high score for homogeneity may obscure 
its ability to detect changes [44]. In clinimetrics, homoge-
neity of components is not requested and single items may 
be weighed in different ways: what matters is the capacity 
of an index to discriminate between different groups of 
subjects and to reflect changes in experimental settings 
such as psychotropic drug or psychotherapy trials [9, 49]. 
As a result, on the basis of the available literature, some 
specific features of mental pain in the clinical setting were 
identified.
1 Presence of mental pain. This is the first clinical require-
ment. Questions such as “Do you feel pain and suffering 
in your mind that goes beyond what one may experi-
ence in life from time to time? How would you describe 
it? How does it compare with physical pain?” may be a 
helpful start. In our clinical experience patients are un-
likely to spontaneously report mental pain unless they 
are specifically questioned about it. When they are en-
couraged, they may provide very vivid descriptions. 
2 Feeling of being wounded. Mental pain has been char-
acterized as a state of “feeling broken” that involves the 
experience of being wounded, with loss of self and dis-
connection from others [14, 23]. Expressions such as 
“my heart is broken” reflect this state.
3 Sense of helplessness and hopelessness. Mental pain 
may be increased by feelings of helplessness (the per-
ception of being unable to cope with some pressing 
problems and/or of lack of adequate support from oth-
Table 1. The Mental Pain Questionnaire (MPQ)
Mental Pain Questionnaire (MPQ)
Mental or psychological pain is an experience that is part of life. It is different from physical pain. We would 
like to learn about your experience of mental pain in the past week. There is no right or wrong answer. Please 
work quickly.
1. I feel pain yes no
2. My heart is broken yes no
3. I will never find again what I have lost yes no
4. My pain is everywhere yes no
5. My pain is with me all the time yes no
6. I cannot understand why I feel this pain true false
7. I feel empty yes no
8. My life makes no sense true false
9. My pain will never go away true false
10. The only way to stop my pain is to die true false
Scoring for each item: yes/true = 1, no/false = 0; total score range: 0–10. From Fava [47].
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ers) or hopelessness (the consciousness of having 
failed to meet expectations associated with the convic-
tion that there are no solutions for current problems 
and difficulties) [5, 50]. Hopelessness/giving-up may 
increase the perception of mental pain and thus needs 
to be distinguished from helplessness [51].
4 Pain location. One of the characteristics of mental pain 
is the fact that it cannot be localized in a part of the 
body. The term “central pain” has been used, particu-
larly in reference to depression, where the system is 
disinhibited, with distress arising from stimuli that 
were previously non-aversive [52–54]. 
5 Duration of pain. It is of crucial importance how men-
tal pain is perceived by the individual as such to get an 
idea of its duration, persistence, and potential chronic-
ity. Questions such as “Does it hurt all the time or in 
specific moments? Does it occur every day or less fre-
quently? Is there anything that makes it worse? Is there 
anything that makes it better?” may provide further 
helpful specifiers.
6 Relation to events and situations. Some patients may 
date its beginning in relation to a certain event or situ-
ation, whereas other people are unable to track a spe-
cific time of onset. Lack of understanding the occur-
rence of mental pain is likely to increase the perception 
of pain.
7 Feelings of emptiness. Feeling numb or empty may be 
another clinical characteristic of mental pain. Such 
feelings were found to differentiate major suicide 
 repeaters and non-major suicide repeaters [55]. 
8 Loss of meaning of life. Emptiness may be increased by 
loss of meaning in life [56]. Frankl [56] suggested that 
suffering terminates at the moment a meaning is found 
for it.
9 Irreversibility of pain. When mental pain is of long du-
ration it may engender the conviction of its irrevers-
ibility, as well as fears and intolerance of suffering.
10 Relationships with suicidal ideations. Suicide risk is 
much higher when the general psychological and emo-
tional pain reaches intolerable intensity [18, 57, 58] in 
relation to the individual pain tolerance threshold 
[16], particularly in the context of major mood disor-
ders [59]. Patients may come to believe that the only 
way to stop pain is to die.
These 10 characteristics were translated into 10 simple 
self-rated formulations. The MPQ has shown good clini-
metric properties when administered in a clinical popula-
tion of 200 migraine patients [60], particularly sensitivity 
in discriminating between patients with or without psy-
chological distress, and incremental validity (according 
to which each distinct aspect of psychological measure-
ment should deliver a unique increase in information in 
order to qualify for inclusion). In another investigation 
on 200 primary care patients [61], the MPQ significantly 
discriminated between patients presenting with at least 
one DSM-5 [62] or Diagnostic Criteria for Psychosomat-
ic Research (DCPR) [5] diagnosis and those who had no 
diagnosis, displaying good sensitivity and discriminating 
between different patient subgroups. There were highly 
significant correlations between the MPQ and both ob-
server- and self-rated scales of psychological distress [60, 
61], such as the Clinical Interview for Depression [63] 
and the Psychosocial Index [64]. The MPQ was also sig-
nificantly negatively correlated with the Euthymia Scale 
[65, 66]. These preliminary data suggest that the MPQ 
may satisfy the clinimetric requirements to qualify as a 
PRO measure.
The Transdiagnostic Features of Mental Pain
In 1967, Eysenck [67] referred to neuroticism and in-
troversion by the term “dysthymia.” The term then be-
came synonymous with chronic depression, but its origi-
nal definition [67] provides the conceptual ground for the 
clinical transdiagnostic balance between euthymia (char-
acterized by environmental mastery, resilience, flexibili-
ty, cheerfulness, relaxation, interest in things) and dys-
thymia (encompassing high reactivity to environmental 
stimuli, subjective incompetence, demoralization, rigid-













Fig. 1. Transdiagnostic balance between euthymia and dysthymia.
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The transdiagnostic features of mental pain are sup-
ported by its association with a number of psychiatric dis-
orders. Mental pain can be considered as a specifier for 
DSM-5 “clinically significant distress” caused by the 
symptoms of a psychiatric disorder [62]. Depression is 
inextricably linked to its experience: patients may present 
with a uniquely aversive, anguished, or uncomfortable 
experience that is characterized by painful tension and 
torment [52–54, 70]. They may become suicidal when 
they perceive their emotional state as painful and inca-
pable of change.
However, mental pain can also occur independently 
from depression. It may be associated with anxiety disor-
ders [61], such as in the perception of invalidism in ago-
raphobia or social barrier in social anxiety. In anorexia 
nervosa, the select mental focus on food and eating has 
been found to be related with emotional avoidance [71] 
and patients often report feeling emotionally “numb.” 
When qualitative assessment methods were applied [72], 
anorexic patients reported that their illness helped them 
to avoid or control aversive emotions and high sensitivity 
to emotional pain. 
Patients with borderline personality disorder have a 
range of intense dysphoric affects, sometimes experi-
enced as aversive tension, including rage, sorrow, shame, 
panic, terror, and chronic feelings of emptiness and lone-
liness. These individuals can be distinguished from other 
groups by the overall degree of their multifaceted mental 
pain [73, 74], which has been associated with a high prev-
alence of reported childhood maltreatment [75]. Deliber-
ate self-harm may serve to shift attentional focus away 
from emotional pain and toward physical pain [76].
Mental pain has also been described in the setting of 
post-traumatic stress disorder [77], obsessive-compul-
sive disorder [78], schizophrenia [79], and grief [22]. 
There may be considerable overlaps, even in brain net-
works, with pain of somatic origin [11, 12, 80]. The char-
acteristics of mental pain associated with medical disease, 
however, have not been sufficiently explored. Engel [81] 
observed that some individuals are more prone than oth-
ers to use physical pain as a psychic regulator, whether 
the pain includes a peripheral source of stimulation or 
not. These patients have been defined as “pain-prone” 
[81, 82].
Finally, the subjective experience of mental pain may 
be influenced by spiritual and religious factors. Accord-
ing to Wachholtz and Fitch [83], chronic pain conditions 
may be influenced by religious beliefs and active use of 
prayer may be a primary form of coping. Religious/spiri-
tual beliefs, however, may have powerful negative impact 
on the perception of pain. The Italian scholar of biblical 
studies Ortensio da Spinetoli [84] underscored how a cer-
tain interpretation of the Catholic religion may link suf-
fering to guilt and expiation as a well-deserved punish-
ment, despite lack of any biblical evidence to support such 
a stance.
Treatment of Mental Pain
Assessment of mental pain may have important impli-
cations in intervention research, particularly in psycho-
pharmacology and psychotherapy, and yet it has been ig-
nored. For instance, depressed patients frequently report 
that treatment with antidepressant drugs yields substan-
tial relief of their mental pain. This would be consistent 
with the decrease in reactivity to social environment that 
has been found in placebo-controlled trials with antide-
pressant drugs using Paykel’s Clinical Interview for De-
pression [63]. It would also be consistent with Carroll’s 
neurobiological model of central pain [54]. In the de-
pressed phase, the central nervous system is seen as dis-
inhibited, so that stimuli that previously were non-aver-
sive are experienced as distressing and lead to agitation, 
pathological guilt, and hopelessness [54]. The findings of 
van Heeringen et al. [85] indicate that dorsolateral hyper-
activity is associated with increased levels of mental pain 
in depression. It is a common clinical experience to ob-
serve relief of mental pain by the use of other psychotro-
pic drugs, such as benzodiazepines [86, 87] or antipsy-
chotics [88]. Since improvement in variables associated 
with mental pain may also occur with placebo [89], one 
may wonder what is the specific role of psychopharma-
cology. We need to test and compare psychotropic drugs 
in randomized placebo-controlled trials, with mental 
pain as a PRO. 
With regard to psychotherapy, relief of mental pain 
has been associated with non-specific therapeutic ingre-
dients such as attention and opportunities for disclosure 
in a high arousal state [5, 49]. In recent years, there has 
been increasing interest in the role of positive affects in 
pain and its treatment [90, 91]. Since positive affects have 
been found to attenuate both the perception of physical 
pain and its psychological responses [90], it is conceiv-
able, and yet to be tested, that a specific psychotherapeu-
tic strategy for modulating well-being, Well-Being Ther-
apy (WBT), may counteract the manifestations of mental 
pain [47]. It is also conceivable that appropriately using 
spiritual resources [92] may lead to clinical improve-
ment.
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Mental Pain and the Opioid Epidemic
In recent years, the opioid abuse epidemic has gained 
increasing visibility [93]. In the USA, in 2016 more than 
11 million Americans misused prescription opioids, and 
opioid-related death has claimed more than 300,000 lives 
since 2000. The majority of people started with painkill-
ers, and problematic prescription of opioids is often cited 
as a primary contributor to the current epidemic [94]. 
Individuals with chronic pain are commonly prescribed 
opioids for its treatment and are at risk for developing 
opioid abuse [94]. The role of mental pain in such a pop-
ulation has been insufficiently explored, even though it 
can be inferred by the use of antidepressant drugs or re-
lated substances in the management of somatic pain [12]. 
Addressing mental pain, whether accompanied or not by 
somatic manifestations, may be an important pathway to 
prevent and diminish the opioid epidemic. Garland et al. 
[95] conducted a randomized controlled trial involving a 
psychotherapeutic protocol geared to mindfulness and 
positive emotions compared to a support group in chron-
ic pain patients who abused opioids. The intervention sig-
nificantly reduced opioid misuse and craving while de-
creasing pain syndromes.
Conclusions
The data we summarized indicate that there is a press-
ing need for research assessing mental pain in medical and 
psychiatric settings. According to the clinimetric approach, 
mental pain should be incorporated, among other impor-
tant psychological variables, into current psychiatric as-
sessment and may yield specific clinical features of pa-
tients’ psychological distress. Further, mental pain should 
be included as a PRO measure in treatment outcome stud-
ies and may become a very important indicator of the ef-
fectiveness and usefulness of interventions, particularly 
with regard to psychopharmacology and psychotherapy. 
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